Please select an option below to help us tailor your newsletter to best suit your content interests!
This past weekend, Drs. Bradley Somer, Gregory Vidal, and Jason Porter hosted presentations at the Best of ASCO – Memphis Conference! This Post ASCO review showcased abstracts from highly rated presentations and the latest research in oncology education. Our physicians helped lead several discussions including: Dr. Jason Porter: – “Personalizing Treatment for Adult Patients with… Read more »
West Medical Oncologists, Dr. Bradley Somer and Dr. Gregory Vidal are two of the presenters for the upcoming Best of ASCO – Memphis Conference. Dr. Vidal will host two sessions: the SEEK Workshop Primer Panel and Diversity in Cancer Care, while Dr. Somer will host a session on GU Cancers. This Post ASCO Review will… Read more »
Through research and partnerships across the oncology community, we are committed to closing the gap in existing disparities in cancer care. A new study in partnership with Dr. Gregory Vidal and our West family, OneOncology, Genentech, and Flatiron Health examined elements of inequity in next generation sequencing (NGS) for patients with advanced non-small cell lung… Read more »
ASCO2023 is in full swing, and our docs are learning from and presenting information to physicians from across the globe about cancer care! West Radiation Oncologist, Dr. Matthew Ballo, shared his hands-on experience in the utilization of Tumor Treating Fields against glioblastoma. Ballo, alongside several fellow physicians, authored a poster presented at ASCO (American Society… Read more »
West Cancer Center is the region’s comprehensive leader in adult cancer care and research, delivering a complete continuum of care to more than 52,000 individuals each year. The National Committee for Quality Assurance (NCQA) is a private, not-for-profit organization dedicated to improving health care quality. The NCQA seal is a reliable indicator that an organization... Read more »
Oral Abstract Session: Melanoma/Skin Cancers Sunday, June 6, 2021; 8:00 AM–11:00 AM EDT 9501 Final analysis of overall survival (OS) and relapse-free-survival (RFS) in the intergroup S1404 phase III randomized trial comparing either high-dose interferon (HDI) or ipilimumab to pembrolizumab in patients with high-risk resected melanoma. KF Grossmann, M Othus, SP Patel, et al Take-Home Message The… Read more »
Our West family is proud to have several of our oncologists publish research being presented at the upcoming American Society of Clinical Oncology Meeting, taking place June 4 – 8. West Cancer Center doctors Schwartzberg, Grothey, A. VanderWalde, Vaena, Vidal and ElNaggar are some of the renowned physicians being recognized at this esteemed event for… Read more »